Ultragenyx Pharmaceutical (RARE) EBIT Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 2,908.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,908.00 |
| Dec 31, 2025 | 8,626.00 |
| Sep 30, 2025 | 14,128.00 |
| Jun 30, 2025 | 9,368.00 |
| Mar 31, 2025 | 6,805.00 |
| Dec 31, 2024 | 4,871.00 |
| Sep 30, 2024 | 1,540.00 |
| Jun 30, 2024 | 1,603.00 |
| Mar 31, 2024 | -4,471.00 |
| Dec 31, 2023 | 913.00 |
| Sep 30, 2023 | -8,622.00 |
| Jun 30, 2023 | -3,443.00 |
| Mar 31, 2023 | 17,898.00 |
| Dec 31, 2022 | 12,446.00 |
| Sep 30, 2022 | 20,936.00 |
| Jun 30, 2022 | 30,727.00 |
| Mar 31, 2022 | 37,504.00 |
| Dec 31, 2021 | 43,257.00 |
| Sep 30, 2021 | 65,208.00 |
| Jun 30, 2021 | 64,658.00 |
| Mar 31, 2021 | 79,647.00 |
| Dec 31, 2020 | 450,618.00 |
| Sep 30, 2020 | 4.22 Mn |
| Dec 31, 2019 | 141.07 Mn |
| Sep 30, 2019 | 5.88 Mn |
| Jun 30, 2019 | 34.10 Mn |